Researchers show that different patient responses to statins can be explained by the variation in the human microbiome. The findings suggest that microbiome monitoring could be used to help optimize personalized statin treatments.
Click here for original story, Gut microbiome composition predictive of patient response to statins
Source: ScienceDaily